Tag: Breakthrough Therapy
May 23, 2019
Tonix Pharmaceuticals Expands Pipeline with Mid-Stage Biologic Candidate
Tonix Pharmaceuticals (NASDAQ:TNXP) has announced that it has in-licensed a Phase 2 asset, TNX-1300 for treating cocaine intoxication. As quoted... April 24, 2019
La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118
La Jolla Pharmaceuticals (NASDAQ:LJPC) has announced the US Food and Drug Administration (FDA) has granted the company breakthrough therapy designation... June 12, 2018